A reminder of a brilliant day and one of our most important projects to date 💙 #AScarfForLewy

If your science is not going right, go left... Or try to enjoy a weekend, I hear taking breaks helps 😉

Want to learn what is up and coming in the world of DLB? Want to meet the next generation of DLB researchers? Then join the NextGen DLB webinar on May 26 and 27! nextgendlb.com/webinars/regis…

Often is debated if DLB and PDD are different phenotypic expressions of the same underlying process.🧠In our study MDS, DLB and PDD showed similar rates of cognitive and motor decline. This is relevant for future clinical trial designs …mentdisorders.onlinelibrary.wiley.com/doi/full/10.10…

I'm thrilled with this wonderful news🧠!! Can't wait for #ADPD2024 #Lisbon🇵🇹 next to the talented Carla Abdelnour

Debate persists: are DLB & PDD distinct phenotypes? 🧠 In a study by Maria Camila Gonzalez in Movement Disorders Clinical Practice, we showed that DLB and PDD patients experienced similar rates of cognitive and motor decline. This is relevant for future clinical trial designs. …mentdisorders.onlinelibrary.wiley.com/doi/abs/10.100…

A longitudinal look at preclinical #Alzheimers in blood. 🩸 #pTau181 & #GFAP increase during preclinical AD 🧬#APOE ε4 carriers have faster increase 👩Females show more acceleration in GFAP 🩸#Aβ & #pTau231 are abnormal earlier Congrats to Yara Yakoub pubmed.ncbi.nlm.nih.gov/37294682/

Let's turn Latin America purple Federico Rodríguez-Porcel Maria Camila Gonzalez Carla Abdelnour Agustin Ibañez Miguel G. Borda M.D, PhD 🇪🇨🇨🇱🇻🇪🇨🇴🇨🇷🇧🇴🇵🇾🇺🇾🇵🇦🇳🇮🇵🇾🇸🇷🇬🇾

🌟Exceptional reviews for ParkinsonNet Norway at @arendalsuka! 🌟 The future for providing care in #Parkinsons looks promising with our model 🚀 Read more in Dagens Medisin #ParkinsonNetNorway #Arendalsuka #Healthcare dagensmedisin.no/arbeiderpartie…

Carla Abdelnour (Stanford Neurology & Neurological Sciences) discusses her study of p-tau181 to identify AD co-pathology in DLB p-tau181 successfully identified AD co-pathology & predicted those who were likely to decline more quickly over 6 years of follow-up: tinyurl.com/3yapnby7 #AAIC23

First LARGE-PD meeting in the books! It was an in redoble experience , all thanks to this amazing group of people who are compromised with improving things for people with Parkinson’s in Latinoamérica! Proud to be part of this effort! Thank you Cali 🇨🇴

Talking to SelectScience about blood tests for #Alzheimers disease and how Quanterix technology has made this possible

“What is important in science is to understand that one should not be too bound to the dogma. You have to be ready for the unexpected.” - 2020 chemistry laureate Emmanuelle Charpentier, awarded the #NobelPrize “for the development of a method for genome editing.”

Job Opportunity!! We have just opened a postdoc position in my lab. If you want to do neuroimaging research at a very nice scientific environment with multiple opportunities please apply here: ki.varbi.com/en/what:job/jo…

#ADPD has become a cherished ritual. I'm excited to see dear colleagues, remarkable discoveries, and the great science that lies ahead. Can’t wait to see you all in Lisbon🇵🇹 #ADPD2024 #Lisbon 🧠

We had our plenary #edlbconsortium meeting today🧠 our Hub leaders presented their amazing progress and bright future in DLB research. Great start for this #ADPD2024 week

We are here 🤓amigos #ADPD2024

#ADPD24 I was thrilled to share additional findings from the European DLB consortium at this year's ADPD conference. It's a fantastic opportunity to meet the co-authors and showcase these results! #edlbConsortium

Meet our #NeuroSpeaker Ceci Fernández, MD! 🌐 She will be part of Buenos Aires Hub 2025 to present "Prodromal Lewy Body Dementia" Don't miss her presentation! Register now: 📎 bit.ly/NeuroscienceNe… #AAIC #Fleni #lewybody #Argentina #dementia #endalz #neurology Lucía Crivelli

This week Dag Aarsland and Maria Camila Gonzalez presented at the International Lewy Body Dementia conference in Amsterdam, sharing progress on their project on the new Neuronal Synuclein Disorder framework in their European DLB cohort. Read more here: e-dlb.com